AI Article Synopsis
- This study assessed the impact of pharmacist counseling on Malaysian smokers' awareness and willingness to quit smoking during a public health campaign.
- After receiving counseling about smoking cessation strategies and related diseases, participants demonstrated significant improvements in their awareness levels regarding smoking.
- Ultimately, 67% of smokers expressed a desire to quit, suggesting that pharmacist counseling effectively aids in smoking cessation efforts.
Article Abstract
Objectives: This paper presents an outcome of pharmacist counseling among Malaysian smokers for their awareness of and willingness to quit smoking.
Method: It was a cross-sectional study during a 3-day public health campaign at a shopping complex. Each self-referred participant was asked to complete a questionnaire apart from the question regarding improvement, and if any in their awareness and willingness to quit smoking, were asked to respond after counseling. Pharmacists counseled each participant about smoking cessation strategies and smoking related diseases. The data were analyzed by chi2 test.
Results: Among respondents, 25.5% had been smoking for more than 10 years, 31% for 5-10 years, 25.4% for 2-5 years and 18.3% for 1-2 years. The participants declaring no awareness about smoking were 22.9%, with little awareness 44.3%, having moderate awareness 25.7% and with considerable awareness were 7.1%. After counseling, 4.1% revealed unawareness, 17.8% little awareness, 43.8% moderate and 34.2% had considerable awareness on the above aspects. The post counseling awareness on smoking was observed to be significantly higher (P < 0.01). Among smokers studied, 67% showed willingness to quit smoking.
Conclusion: Increase in awareness of and willingness to quit smoking reflects that pharmacist counseling seems to be helpful in cessation of smoking.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11096-005-2905-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Self-Reported Comfort and Use of Tobacco Cessation Interventions by Healthcare Providers.
Cureus
November 2024
Department of Public Health Sciences, Penn State University College of Medicine, Milton S. Hershey Medical Center, Hershey, USA.
Background The effects of tobacco use create a significant burden on the American healthcare system. The U.S.
View Article and Find Full Text PDFMotivators and barriers for smoking cessation in people with multiple sclerosis: a qualitative study to inform the design of a tailored intervention.
BMC Public Health
December 2024
Institute of Neuroimmunology and Multiple Sclerosis (INIMS), University Medical Centre Hamburg- Eppendorf, Martinistrasse 52, Hamburg, 20246, Germany.
Background: Tobacco smoking is a relevant determinant of multiple sclerosis (MS) onset, and smokers have increased risk for faster progression of MS compared to non-smokers. While the smoking prevalence is high in Germany, no smoking cessation programs have been developed specifically in MS populations to date, and only little is known about the motivators and barriers influencing smoking cessation in people with MS (pwMS) in Germany. This study aims to identify these factors to inform the design of a tailored smoking cessation intervention.
View Article and Find Full Text PDFLesions to different regions of frontal cortex have dissociable effects on voluntary persistence.
J Neurosci
November 2024
Department of Psychological and Brain Sciences, Boston University, Boston, MA 02215.
Deciding how long to keep waiting for uncertain future rewards is a complex problem. Previous research has shown that choosing to stop waiting results from an evaluative process that weighs the subjective value of the awaited reward against the opportunity cost of waiting. Activity in ventromedial prefrontal cortex (vmPFC) tracks the dynamics of this evaluation, while activation in the dorsomedial prefrontal cortex (dmPFC) and anterior insula (AI) ramps up before a decision to quit is made.
View Article and Find Full Text PDFEfficacy of Inpatient, Evidence-Based Tobacco Use Treatment of Patients With Bladder Cancer After Radical Cystectomy.
Clin Genitourin Cancer
October 2024
Department of Urology, University of North Carolina at Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC. Electronic address:
Purpose: Despite a 3-fold increase in risks of bladder cancer (BC) among current smokers, smoking cessation therapy for patients undergoing treatment is significantly underutilized. Inpatient admission after surgery provides a teachable moment to pursue tobacco treatment. We conducted a 12-month prospective quality improvement initiative to increase tobacco treatment program (TTP) consultations with BC patients who smoke and underwent radical cystectomy (RC).
View Article and Find Full Text PDFTobacco use and readiness to treat tobacco users among primary healthcare professionals in Soweto.
S Afr Fam Pract (2004)
October 2024
Department of Family Medicine and Primary Care, Faculty of Health Sciences, School of Medicine, University of the Witwatersrand, Johannesburg.
Background: Despite its hampering influence on the willingness of healthcare professionals (HCPs) to implement tobacco cessation treatments, the tobacco use status of these professionals remains understudied in South Africa.
Methods: This cross-sectional study, which sampled 444 HCPs, was conducted in five community health centres in Soweto. A self-administered questionnaire collected information on socio-demography, tobacco use, quit attempts and readiness to implement tobacco cessation treatments for their patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!